SPR, BLI, ITC, MST or STD-NMR: Choosing a Binding Assay

01Scope and Rationale

An outsourced binding study should help your team make a defined decision: retain a hit, compare analogs, characterize an antibody interaction, or investigate conflicting measurements. If association and dissociation behavior are central to that decision, SPR binding analysis services are one route to discuss. Other methods may fit your samples or question better. You can begin with the target, binding partner, available quantities, and desired output rather than having to choose the instrument yourself.

Begin with the output you need

Binding assays can answer related but distinct questions: whether a molecule interacts with a target, how interaction strength changes across a series, how quickly association and dissociation occur, or what thermodynamic behavior accompanies binding. Choosing a method begins by stating which answer will change the project decision. A fitted number is only useful when the underlying experiment supports the model used to obtain it.

Surface plasmon resonance (SPR) and bio-layer interferometry (BLI) monitor surface-associated binding responses. Isothermal titration calorimetry (ITC) measures heat during a titration. Microscale thermophoresis (MST) detects changes in molecular behavior in a temperature gradient, commonly using a fluorescence readout. Saturation transfer difference NMR (STD-NMR) investigates ligand recognition through magnetization transfer. These descriptions identify broad principles, not a guarantee that every target or interaction will be measurable in a particular implementation.

Do not treat the methods as interchangeable ways to obtain the same data. A project investigating residence behavior requires a different plan from one screening weak fragments. A study comparing a protein–protein interaction may have different surface and concentration constraints from a small-molecule campaign. Even when two methods report affinity, the relevant molecular state, buffer, and binding model should be considered before comparing numbers.

Understand the distinction between binding and function

A binding measurement does not automatically demonstrate inhibition, activation, selectivity, or cellular engagement. Conversely, an activity response does not prove direct binding to the intended target. Plan functional experiments separately where those claims matter. A complementary biophysical result can strengthen an interpretation, but the entire evidence chain must remain explicit.

For planning purposes, separate the first feasibility experiment from the full characterization campaign. The first study may establish whether the sample remains suitable or whether the assay response can be interpreted. That outcome is useful even if a precise affinity is not obtained. It prevents a project from scaling an unsuitable setup merely because the method is widely used elsewhere.

Match the method to material and risk

Consider how much sample is available, whether it tolerates immobilization or labeling, and whether a reliable concentration can be established. Review solvent, buffer, cofactors, and potential nonspecific interactions. Identify the artifact most likely to mislead the result and choose controls accordingly. The best starting method is the one that can address the question under these constraints, rather than the one with the most attractive generic sensitivity claim.

Compare the practical questions behind each method

For SPR, ask whether the target or a binding partner can be presented on the sensor surface while retaining the relevant state. Review the expected response relative to background, the concentration range, and whether the experiment is intended to support equilibrium or kinetic interpretation. A surface with a large loading signal is not necessarily a surface with a suitable active population. Reference channels and regeneration conditions should address the intended comparison.

For BLI, ask how sensor loading, matrix composition, and sample handling will be controlled. A capture approach that works for one biologic may not transfer directly to a small-molecule project. Background subtraction and concentration-dependent behavior need review before association or dissociation parameters are accepted. The practical choice between BLI and SPR should follow the actual materials and analytical question rather than a generic statement about which instrument is faster.

For ITC, establish whether both materials can be prepared at reliably known concentrations in compatible solutions. Consider the heat of dilution and whether the expected binding-associated signal is distinguishable from other processes. Stoichiometry inferred from a fit can be affected by concentration or active-fraction uncertainty. An unexpected value should trigger review of those possibilities before being assigned a new mechanistic explanation.

For MST, clarify how the observed species is detected and whether compound addition changes fluorescence independently of binding. Review concentration-dependent sample behavior and capillary-related effects. If labeling is used, consider its location and the possibility that it changes the interaction. A small required volume can be attractive for scarce material, but sufficient controls remain essential for deciding whether the observed transition supports the proposed interaction.

For STD-NMR, assess the relevant spectra and experimental conditions before planning a full fragment set. Signal overlap and compound behavior can limit interpretation. A negative observation under one configuration should not automatically exclude all forms of binding, while a positive observation should be examined for nonspecific effects. The method's value is strongest when its evidence is connected to a clear recognition question and suitable confirmation.

Use a comparison plan instead of a winner-takes-all method choice

Illustrative planning example, not a company case study: an immobilized target produces interpretable binding responses for several compounds, but a related preparation shows inconsistent results. Before concluding that the methods disagree about affinity, compare construct, active fraction, chemical material, and assay conditions. A solution-oriented measurement may help investigate a surface-related hypothesis, but it must first be assessed for its own sample and detection constraints.

If both experiments are technically valid yet probe different states, the discrepancy may be scientifically meaningful. Preserve it in the report and decide whether resolving the state difference matters for the project. If the immediate goal is selecting a small chemistry set, the team may proceed with a qualified comparison while planning targeted follow-up. If a definitive mechanism claim is required, additional evidence may be necessary before drawing that conclusion.

02Step-by-Step Binding Assay Selection

1. 1

   Define the claim and the comparison

   Write the intended conclusion before selecting the instrument: evidence for interaction, a concentration-dependent affinity estimate, kinetic comparison, or thermodynamic characterization. Specify the molecules and molecular state involved. Include whether the ligand is a fragment, a larger small molecule, a peptide, or a biologic. Consider whether a partner or cofactor is required to reproduce the relevant target context.

   Decide what comparison will justify advancement. If compounds are being ranked, establish whether the expected differences exceed experimental uncertainty. If the experiment investigates a mechanism, specify which alternative explanation would produce similar observations. This prevents an isolated result from being assigned a broader meaning than the study can support.

2. 2

   Assess whether a surface method fits

   SPR measurements can support real-time interaction analysis when the immobilized or captured sample and the solution-phase analyte are suitable. Review orientation, active surface fraction, nonspecific binding, mass transport, regeneration, and the concentration range. Inspect sensorgrams and residual behavior rather than relying on the presence of a fitted kinetic model.BLI measurements provide another surface-based approach. Evaluate sensor chemistry, loading, reference subtraction, and sample matrix effects. The absence of a microfluidic channel does not remove every transport or surface limitation. Both SPR and BLI need evidence that the observed response can answer the intended molecular question.
3. 3

   Consider solution-oriented alternatives

   ITC characterization can investigate binding-associated heat and, where the experiment and model are appropriate, support affinity and thermodynamic interpretation. Examine concentration accuracy, dilution heat, buffer effects, sample consumption, and whether the interaction falls within an informative experimental range. A weak or complex heat signal should not be forced into a simple binding model.

   MST can be considered where the detection configuration, sample, and binding-related change are suitable. Review labeling or intrinsic fluorescence assumptions, adsorption, aggregation, fluorescence changes, and the dilution series. It is not automatically immune to optical or sample artifacts because it uses relatively small volumes. A feasibility check should establish a reproducible measurement window before a complete compound series is committed.

4. 4

   Select a fragment-recognition strategy

   STD-NMR fragment screening can be useful for suitable protein–ligand systems. Evaluate ligand solubility, spectral overlap, exchange behavior, protein condition, and the possibility of nonspecific effects. A positive STD observation supports a recognition hypothesis under the experiment's conditions; it does not by itself provide a resolved three-dimensional binding pose or a general affinity value.

   Design complementary confirmation according to the original question. Competition experiments may help investigate site overlap, while another binding method or structural measurement may address different uncertainty. The label “orthogonal” should describe the independence of the relevant evidence, not simply the fact that a second technique was used.

5. 5

   Run feasibility controls before full characterization

   Use suitable blank conditions, references, and sample checks. Examine concentration-dependent behavior and repeatability. Record buffer, temperature, solvent, constructs, sample preparation, and analysis choices. If labeling or immobilization is required, consider whether those changes preserve the molecular state being investigated. A reference interaction can help assess setup performance when one is available, but should not be invented when it is absent.

   Define how inconclusive data will be reported. A sample that precipitates, a surface that loses activity, and a compound that gives a reproducible negative result are different outcomes. Treating them all as “no binding” loses information and can lead the chemistry team to reject a valid hypothesis for the wrong reason.

6. 6

   Compare methods using conditions and uncertainty

   When results disagree, first compare the exact materials, molecular states, concentrations, buffer conditions, and model assumptions. Ask whether each measurement was technically interpretable and whether both methods were sensitive to the same interaction. The discrepancy may reveal a surface effect, sample change, multivalent behavior, or another property worth investigating.

   Do not average incompatible results into a seemingly definitive number. Report the difference and design a limited follow-up that distinguishes the plausible explanations. If the intended decision is compound ranking, identify whether the ranking is stable within each method and whether remaining uncertainty changes the next chemistry choice. A transparent qualified result is more useful than false precision.

03Common Pitfalls and How to Avoid Them

• Choosing an assay only by its advertised sensitivity

  Generic sensitivity ranges do not describe every target, analyte, matrix, and configuration. Evaluate feasibility with the actual materials. A method that is sensitive in principle can still be uninformative when the sample is unstable or the measurement does not distinguish specific binding from background.

• Treating every curve as a simple one-site interaction

  Inspect response shape, concentration dependence, controls, and model suitability. Heterogeneity, avidity, transport effects, and nonspecific interactions can complicate analysis. A successful fit is not sufficient evidence that all fitted parameters have a physically meaningful interpretation.

• Ignoring sample preparation differences

  Protein concentration, active fraction, ligand identity, solvent content, and storage can affect interpretation. Track batches and handling. A result obtained with one construct or modified preparation should not be assumed interchangeable with another without considering whether the relevant interaction context is preserved.

• Calling two measurements independent without checking artifacts

  Aggregation, unsuitable solvent, or degraded material can influence more than one technique. Choose controls that address the suspected mechanism of interference. Agreement across methods strengthens a conclusion only when the observations are interpretable and support the same defined claim.

04Deliverables

Agree on the report before running the study, including the meaning of negative and inconclusive outcomes. The package should distinguish direct observations, fitted parameters, and biological interpretations. Not every project requires all five methods or every form of characterization.

• An assay selection rationale

  Explain the research question, sample constraints, selected method, and important alternatives. State which properties will be measured and which claims remain outside scope. Include the reason for any surface, labeling, or buffer strategy used.

• Methods and sample traceability

  Record constructs, compound identifiers, batches, preparation, concentrations, buffers, temperature, and controls. Include relevant modifications such as capture, immobilization, or labeling. These details support comparison and help identify whether discrepancies could arise from the experimental material.

• Interpretable measurements and analysis

  Provide agreed raw and processed data, reference corrections, model assumptions, and quality assessment. Report uncertainty and limitations where applicable. Do not replace an uninformative experiment with an unsupported affinity estimate merely to populate a spreadsheet.

• A project-focused interpretation

  Explain what the study supports about interaction, affinity, kinetics, or thermodynamics. Separate those conclusions from functional activity and cellular engagement. Recommend the next measurement only when it could change the research decision or resolve an important uncertainty.

05Integrated Research Solutions

Request a measurement that matches your project decision

Creative Biostructure offers biophysical characterization approaches including SPR, BLI, ITC, MST, and STD-NMR-related work. When contacting the team, describe the molecular interaction and the decision you want the measurement to support. A request to compare affinity across an analog series differs from a request to characterize association and dissociation, confirm a weak fragment interaction, or investigate a suspected assay artifact. Matching that purpose to the method is part of defining a useful study.

You can request discussion of a specific assay if your internal workflow already depends on it, or describe the question and ask which approach is appropriate. For a small-molecule interaction, molecular size, solubility, and target behavior may affect method choice. For an antibody or protein interaction, immobilization strategy and binding complexity can be important. Method availability alone does not establish that every sample will support the same analysis.

Prepare samples and information before sending material

For the protein, provide its identity, construct, tags, buffer, concentration, available amount, storage history, and any known activity or stability data. For the binding partner, include its identity or structure, stock concentration, solvent, solubility observations, and prior measurements. Identify essential additives, cofactors, or partners, and whether labeling or immobilization has previously changed sample behavior.

Ask the team to confirm the required material amount and shipping conditions for the agreed setup before dispatch. A small feasibility study and a larger concentration-series study may require different quantities. If sample supply is limited, make that constraint explicit in the initial inquiry so that the proposed plan can prioritize the most informative measurement and distinguish setup work from routine characterization.

Specify what you need beyond a reported affinity value

When comparing quotations, check whether the proposed scope includes assay development, reference and negative controls, concentration series, replicate strategy, and analysis of nonideal behavior. Discuss whether you need sensorgrams, thermograms, or other primary readouts alongside fitted values and interpretation. The report should make clear when an affinity or kinetic parameter is supported and when a more limited conclusion is appropriate.

If two existing methods disagree, send the underlying observations and conditions rather than only the final numbers. A focused comparison may be more useful than repeating both methods without a specific hypothesis. Where complementary characterization is proposed, agree on the uncertainty it will resolve and the sample use involved. This gives your team a basis for deciding whether to proceed to a second measurement, structural work, or further compound testing.

06Frequently Asked Questions

07References

1. 1.
   Auld DS, Farmen MW, Kahl SD, et al. Receptor Binding Assays for HTS and Drug Discovery. Assay Guidance Manual. 2012.
2. 2.
   Arkin MR, Glicksman MA, Fu H, et al. Inhibition of Protein-Protein Interactions: Non-Cellular Assay Formats. Assay Guidance Manual. 2012.
3. 3.
   Auld DS, Inglese J, Dahlin JL. Assay Interference by Aggregation. Assay Guidance Manual. 2017.